Cilgavimab Recruiting Phase 3 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment

Indications	Status	Purpose	Phase
DBCOND0129755 (Coronavirus Disease 2019 (COVID‑19))	Recruiting	Treatment	3

clinicaltrials.gov Identifier	Title	Drugs
NCT05321394	Non-inferiority Trial on Treatments in Early COVID-19	Cilgavimab (DB16393) Nirmatrelvir (DB16691) Ritonavir (DB00503) Sotrovimab (DB16355) Tixagevimab (DB16394)